샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793013

세계의 말라리아 치료 시장

Malaria Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 372 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 말라리아 치료 시장은 2030년까지 224억 달러에 도달

2024년에 53억 달러로 추정되는 말라리아 치료 세계 시장은 2024-2030년의 분석 기간에 CAGR 27.2%로 성장하여 2030년에는 224억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 제네릭 의약품 치료는 CAGR 26.3%를 나타내고, 분석 기간 종료시에는 123억 달러에 이를 것으로 예측됩니다. 오리지네이타 치료 부문의 성장률은 분석 기간중 CAGR 29.5%로 추정됩니다.

미국 시장은 14억 달러로 추정, 중국은 CAGR 35.6%를 보일 것으로 예측

미국의 말라리아 치료 시장은 2024년에 14억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 55억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 35.6%가 됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 22.1%와 24.4%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 22.9%를 나타낼 전망입니다.

세계의 말라리아 치료 시장 - 주요 동향과 촉진요인 정리

말라리아 치료가 전염병이 유행하는 지역 전체에서 공중보건의 우선순위가 되는 이유는 무엇인가?

말라리아 치료는 특히 열대 및 아열대 지역에서 매년 수십만 명이 사망하고, 5세 미만의 어린이가 가장 취약한 위치에 있는 등 그 영향이 광범위하기 때문에 전 세계 공중보건 활동의 주요 초점이 되고 있습니다. 말라리아는 예방과 인식 제고 측면에서 큰 진전을 이루었음에도 불구하고 아프리카, 동남아시아, 일부 라틴아메리카, 오세아니아의 보건 시스템에 계속 도전하고 있습니다. 아노펠레스 모기에 의해 매개되고 말라리아 원충에 의해 유발되는 이 질병은 복잡하기 때문에 대상 종과 지역의 약제 내성 패턴에 따라 다른 표적화된 치료 프로토콜이 필요합니다. 대부분의 경우, 말라리아 원충은 빠르게 증식하고 신속하게 치료하지 않으면 심각한 합병증을 유발할 수 있기 때문에 가장 위험성이 높습니다. 신속한 진단과 효과적인 약물 투여는 이 질병의 부담을 줄이고 확산을 방지하는 데 매우 중요합니다. 빈곤, 노동생산성 저하, 높은 이환율과 사망률과의 연관성 때문에 국내외 보건기관은 말라리아 치료를 전략의 우선순위로 삼고 있습니다. 세계보건기구(WHO)는 합병증 없는 말라리아 치료의 표준이 되고 있는 아르테미시닌 기반 혼합요법(ACTs)을 시행하는 국가들을 지속적으로 지원하고 있습니다. 그러나 아시아와 아프리카 일부 지역에서 약제 내성이 나타나고 있어 지속적인 모니터링과 조사의 필요성이 부각되고 있습니다. 진단법, 약품, 지역 보건 개입에 대한 접근성을 높이기 위한 노력은 말라리아 치료를 단순한 의료 문제가 아닌 감염 지역의 경제 성장과 삶의 질에 영향을 미치는 발전적인 문제로 만들고 있습니다.

의약품 개발 및 진단의 발전이 말라리아 관리를 어떻게 강화하고 있는가?

제약 연구와 진단 분야의 혁신은 말라리아의 진단, 치료 및 관리 방법을 변화시키고, 말라리아를 통제하고 궁극적으로 퇴치하기 위한 노력에 새로운 희망을 가져다주고 있습니다. 아르테미시닌을 기반으로 한 병용요법이 여전히 최전선 치료법이지만, 내성 우려가 커지면서 새로운 제형과 2세대 항말라리아 화합물 개발이 진행되고 있습니다. 연구자들은 특히 농촌 지역이나 자원이 부족한 환경에서 치료 프로토콜을 간소화하고 치료 순응도를 향상시킬 수 있는 단회 투여 치료제, 복합제, 장기 작용 치료제 개발에 집중하고 있습니다. 한편, 신속 진단 검사(RDT)와 같은 현장 진단은 조기 발견을 크게 개선하여 의료진이 고도의 검사 인프라 없이도 다른 원충 종을 구별할 수 있게 해줍니다. 이러한 도구는 적절한 치료법을 결정하고 내성을 가속화하는 항말라리아 약물의 오남용을 피하기 위해 필수적입니다. 또한, 유전체 연구의 발달로 기생충 내성의 진화가 밝혀져 장기적으로 효과를 유지할 수 있는 표적치료제 개발에 도움이 되고 있습니다. 주사용 항말라리아제 및 새로운 정맥주사 제제가 중증 환자들에게 도입되고 있으며, 응급상황에서 환자의 안정화 속도를 높이고 사망률을 낮출 수 있습니다. 신규 엔도퍼옥사이드 화합물, 전달 억제제 등 여러 파이프라인 의약품이 임상시험 중으로 치료 수단의 확대를 목표로 하고 있습니다. 디지털 헬스 툴과 모바일 플랫폼은 발병 추적, 치료 효과 모니터링, 접근이 어려운 지역사회의 확실한 투약에 활용되고 있습니다. 이러한 발전은 환자의 결과를 개선할 뿐만 아니라, 보다 정확한 데이터와 개입 도구를 제공함으로써 공중보건 시스템을 강화하는 데에도 기여하고 있습니다.

말라리아 치료 전략에 영향을 미치는 세계 보건 및 사회경제적 동향은?

세계 공중보건 우선순위와 사회경제적 역학은 말라리아 치료 전략을 수립하고 보건 시스템이 말라리아 발병에 얼마나 효과적으로 대응할 수 있는지를 결정하는 데 있어 매우 중요한 역할을 합니다. 기후 변화, 도시화, 토지 이용의 변화는 모기의 서식지에 영향을 미치고, 말라리아의 감염 패턴을 변화시켜 이전에는 감염되지 않았던 지역까지 감염 범위를 넓히고 있습니다. 이주민과 난민의 이동도 말라리아 확산에 기여하고 있으며, 종종 수용 지역의 보건 인프라에 부담을 주는 경우가 많습니다. 경제적 불평등으로 인해 사회적으로 소외된 사람들이 적시에 진단과 치료를 받을 수 있는 기회가 계속 제한되고 있으며, 말라리아는 빈곤의 원인인 동시에 결과이기도 합니다. 보건부와 국제 기부자들은 특히 질병 부담이 가장 큰 농촌 지역에서 말라리아 치료를 보다 광범위한 1차 의료 서비스에 통합하는 데 점점 더 중점을 두고 있습니다. 민관 파트너십을 포함한 협력적 노력을 통해 효과적인 치료의 지속적 이용에 필수적인 의약품 조달, 현지 제조 및 공급망의 신뢰성을 향상시킬 수 있게 되었습니다. 지역 보건 종사자와 풀뿌리 보건 프로그램은 1차 치료를 시행하고 진단 검사를 실시할 수 있도록 훈련을 받고 있으며, 국가 말라리아 프로그램의 범위를 확장하고 있습니다. 특히 부모와 간병인을 대상으로 한 교육 캠페인에서는 재발과 내성을 피하기 위해 치료 요법을 완료하는 것이 중요하다는 점을 강조하고 있습니다. 정책적 차원에서 각국 정부는 세계기금 및 WHO와 같은 조직과 협력하여 지역 고유의 치료 프로토콜을 시행하고, 연구 이니셔티브를 지원하며, 국제 협력을 촉진하고 있습니다. 이러한 사회경제적, 지정학적 고찰은 말라리아 치료의 복잡성을 부각시키며, 의약품뿐만 아니라 인프라, 교육, 형평성에 초점을 맞춘 정책 등 다각적인 전략의 필요성을 강조하고 있습니다.

세계 말라리아 치료제 시장의 성장을 가속하는 요인은 무엇인가?

세계 말라리아 치료 시장의 성장은 역학적 긴급성, 과학적 혁신, 국제적인 자금 조달, 의료 인프라의 확대가 복합적으로 작용하여 이루어지고 있습니다. 특히 말라리아 원충과 말라리아 원충의 약제 내성 균주의 출현으로 인해 말라리아가 유행하는 지역에서는 말라리아 발생률이 높고, 효과적이고 접근하기 쉬운 치료법에 대한 수요가 지속적으로 증가하고 있습니다. 국제보건기구, 정부, 제약기업의 투자 증가로 새로운 치료법과 진단법 연구 개발이 가속화되고 있습니다. 중저소득 국가에서 의료 서비스 접근성이 확대됨에 따라 ACT 및 관련 약물의 조기 발견과 보다 광범위한 투여가 가능해졌습니다. 생명공학 및 분자생물학의 기술적 발전으로 효능이 향상되고 내성 가능성이 낮은 차세대 항말라리아제 개발이 가능해졌습니다. 정부의 정책 개혁과 의료 보험에 대한 노력으로, 특히 사하라 이남 아프리카 및 동남아시아의 일부 지역에서는 의료혜택을 받지 못하는 사람들의 치료 장벽이 낮아지고 있습니다. 공중보건 교육 및 옹호 캠페인을 통한 인식 개선으로 의료를 찾는 행동과 치료 요법에 대한 순응도가 개선되고 있습니다. 모자보건 서비스에 말라리아 프로그램을 통합함으로써 가장 취약한 생애 단계에서 사례 발견과 개입을 강화할 수 있게 되었습니다. 현지 보건 기관, 비정부기구, 국제 파트너 간의 협력 강화는 더 나은 배포, 모니터링 및 후속 치료를 보장하는 데에도 도움이 되고 있습니다. 이러한 복합적인 요인들이 말라리아 치료제 시장의 강력한 성장을 가속하고, 인명 구조뿐만 아니라 말라리아 감염 지역의 장기적인 시장 개척과 사회적 형평성을 촉진하는 데 있어 세계 보건 보건의 우선순위로 그 중요성이 커지고 있습니다.

부문

치료(제네릭 의약품 치료, 선발 의약품 치료, 백신 치료);유통 채널(병원 약국, 소매 약국, 온라인 유통 채널);투여 경로(경구 투여, 비경구 투여)

조사 대상 기업 예

  • Ajanta Pharma Ltd.
  • Bayer AG
  • BioNTech SE
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Ginkgo Bioworks(via malaria pipeline)
  • GlaxoSmithKline plc(GSK)
  • Guilin Pharmaceutical Co., Ltd.
  • Ipca Laboratories Ltd.
  • Lyndra Therapeutics
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanaria Inc.
  • Sanofi
  • Strides Pharma Science Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.26

Global Malaria Treatment Market to Reach US$22.4 Billion by 2030

The global market for Malaria Treatment estimated at US$5.3 Billion in the year 2024, is expected to reach US$22.4 Billion by 2030, growing at a CAGR of 27.2% over the analysis period 2024-2030. Generic Drug Treatment, one of the segments analyzed in the report, is expected to record a 26.3% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the Originators Treatment segment is estimated at 29.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 35.6% CAGR

The Malaria Treatment market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.5 Billion by the year 2030 trailing a CAGR of 35.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 22.1% and 24.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 22.9% CAGR.

Global Malaria Treatment Market - Key Trends & Drivers Summarized

Why Does Malaria Treatment Continue to Be a Public Health Priority Across Endemic Regions?

Malaria treatment remains a major focus of global public health efforts due to the disease’s widespread impact, particularly in tropical and subtropical regions where it causes hundreds of thousands of deaths annually, with children under five being the most vulnerable group. Despite significant progress in prevention and awareness, malaria continues to challenge health systems in Africa, Southeast Asia, parts of Latin America, and Oceania. The complexity of the disease, which is transmitted by the Anopheles mosquito and caused by Plasmodium parasites, requires targeted treatment protocols that vary depending on the species involved and the drug resistance patterns in the region. In most cases, Plasmodium falciparum poses the highest risk due to its rapid replication and potential to cause severe complications if not treated promptly. Prompt diagnosis followed by effective drug administration is critical to reducing the disease’s burden and preventing its spread. National and international health agencies prioritize malaria treatment in their strategies due to its association with poverty, reduced workforce productivity, and high rates of morbidity and mortality. The World Health Organization continues to support countries in deploying artemisinin-based combination therapies (ACTs), which have become the gold standard for treating uncomplicated malaria. However, the emergence of drug resistance in parts of Asia and Africa has underscored the need for continuous monitoring and research. Efforts to increase access to diagnostics, medications, and community health interventions make malaria treatment not just a medical issue but a developmental one that influences economic growth and quality of life in affected regions.

How Are Advancements in Drug Development and Diagnostics Enhancing Malaria Management?

Innovations in pharmaceutical research and diagnostics are transforming the way malaria is diagnosed, treated, and managed, bringing new hope to efforts aimed at controlling and eventually eliminating the disease. Artemisinin-based combination therapies remain the frontline treatment, but new formulations and second-generation antimalarial compounds are being developed to address the growing concern of resistance. Researchers are focusing on creating single-dose treatments, fixed-dose combinations, and long-acting therapies that simplify treatment protocols and improve adherence, especially in rural or resource-limited settings. Meanwhile, point-of-care diagnostics such as rapid diagnostic tests (RDTs) have significantly improved early detection, allowing healthcare workers to distinguish between different Plasmodium species without the need for sophisticated lab infrastructure. These tools are critical in guiding appropriate treatment decisions and avoiding the misuse of antimalarial drugs, which can accelerate resistance. Additionally, advances in genomic studies are helping scientists understand the evolution of parasite resistance and develop targeted therapies that remain effective over time. Injectable antimalarial drugs and new intravenous formulations are being introduced for severe cases, allowing for faster patient stabilization and reduced mortality in emergency settings. Several pipeline drugs, including novel endoperoxide compounds and transmission-blocking agents, are under clinical trials, aimed at expanding the therapeutic arsenal. Digital health tools and mobile platforms are being used to track outbreaks, monitor treatment efficacy, and ensure medication delivery in hard-to-reach communities. These advancements are not only enhancing patient outcomes but also strengthening public health systems by providing more accurate data and tools for intervention.

What Global Health and Socioeconomic Trends Are Influencing Malaria Treatment Strategies?

Global health priorities and socioeconomic dynamics are playing a pivotal role in shaping malaria treatment strategies and determining how effectively health systems can respond to outbreaks. Climate change, urbanization, and changes in land use are affecting mosquito habitats, leading to shifts in malaria transmission patterns and expanding the range of the disease into previously unaffected areas. Migration and refugee movements are also contributing to the spread of malaria, often straining local health infrastructure in receiving regions. Economic inequality continues to limit access to timely diagnosis and treatment for marginalized populations, making malaria both a cause and consequence of poverty. Health ministries and international donors are increasingly focused on integrating malaria treatment into broader primary healthcare services, especially in rural areas where the disease burden is highest. Collaborative efforts involving public-private partnerships are enabling improved drug procurement, local manufacturing, and supply chain reliability, which are essential for sustained availability of effective treatments. Community health workers and grassroots health programs are being trained to administer first-line treatments and perform diagnostic testing, expanding the reach of national malaria programs. Education campaigns, particularly those targeting parents and caregivers, are emphasizing the importance of completing treatment regimens to avoid relapse and resistance. At the policy level, governments are working alongside organizations like the Global Fund and WHO to implement region-specific treatment protocols, support research initiatives, and facilitate international cooperation. These socioeconomic and geopolitical considerations highlight the complexity of malaria treatment and the need for multifaceted strategies that extend beyond pharmaceuticals to include infrastructure, education, and equity-focused policies.

What Factors Are Driving Growth in the Global Malaria Treatment Market?

The growth in the global malaria treatment market is driven by a combination of epidemiological urgency, scientific innovation, international funding, and expanding healthcare infrastructure. The high incidence of malaria in endemic regions continues to create strong demand for effective and accessible treatments, especially as drug-resistant strains of Plasmodium falciparum and Plasmodium vivax emerge. Increased investment by global health organizations, governments, and pharmaceutical companies is accelerating research and development of new therapies and diagnostics. Expanding access to healthcare services in low- and middle-income countries is enabling earlier detection and more widespread administration of ACTs and related medications. Technological advances in biotechnology and molecular biology are allowing for the development of next-generation antimalarial drugs with improved efficacy and lower resistance potential. Government policy reforms and health insurance initiatives are reducing barriers to treatment in underserved populations, particularly in Sub-Saharan Africa and parts of Southeast Asia. Greater awareness through public health education and advocacy campaigns is improving health-seeking behavior and adherence to treatment regimens. The integration of malaria programs into maternal and child health services is boosting case detection and intervention during the most vulnerable life stages. Increasing collaboration between local health agencies, non-governmental organizations, and international partners is also ensuring better distribution, monitoring, and follow-up care. These collective factors are driving robust growth in the malaria treatment market and reinforcing its importance as a global health priority, not only for saving lives but also for advancing long-term development and social equity in malaria-affected regions.

SCOPE OF STUDY:

The report analyzes the Malaria Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Generic Drug Treatment, Originators Treatment, Vaccines Treatment); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Distribution Channel); Administration Route (Oral Administration, Parenteral Administration)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Ajanta Pharma Ltd.
  • Bayer AG
  • BioNTech SE
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Ginkgo Bioworks (via malaria pipeline)
  • GlaxoSmithKline plc (GSK)
  • Guilin Pharmaceutical Co., Ltd.
  • Ipca Laboratories Ltd.
  • Lyndra Therapeutics
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer Inc.
  • Sanaria Inc.
  • Sanofi
  • Strides Pharma Science Ltd.
  • Torrent Pharmaceuticals Ltd.
  • Zydus Cadila

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Malaria Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Malaria Burden in Endemic Regions Throws the Spotlight on Treatment Innovation as a Global Health Imperative
    • Increasing Focus on Elimination and Control Campaigns Propels Demand for Scalable, Fast-Acting Antimalarial Therapies
    • Here's the Story: Emergence of Drug-Resistant Plasmodium Strains Strengthens the Business Case for Next-Generation Combination Therapies
    • Expansion of Artemisinin-Based Combination Therapy (ACT) Remains the Gold Standard but Faces Pressure from Evolving Resistance Patterns
    • Improved Access to Rapid Diagnostic Tests (RDTs) Supports Timely and Targeted Malaria Treatment Deployment
    • Growth in Pediatric and Pregnancy-Safe Formulations Fuels Inclusion of Vulnerable Populations in Malaria Control Strategies
    • Here's How Mass Drug Administration (MDA) Programs Are Driving Preventive and Community-Based Treatment Demand
    • Global Health Funding from Entities Like WHO, Global Fund, and USAID Sustains Market for Affordable Malaria Treatments
    • Rise in Traveler and Imported Malaria Cases in Non-Endemic Regions Spurs Demand for Prophylaxis and Emergency Treatment
    • Here's How mRNA and Gene-Based Therapeutics Are Emerging as Future Tools Against Drug-Resistant Malaria
    • Integration of Mobile Health Platforms and Supply Chain Tools Enhances Treatment Delivery and Remote Monitoring
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Malaria Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Malaria Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Generic Drug Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Generic Drug Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Generic Drug Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Originators Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Originators Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Originators Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Vaccines Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Vaccines Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Vaccines Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Online Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Online Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Parenteral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Parenteral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • JAPAN
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • CHINA
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • EUROPE
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Malaria Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • FRANCE
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: France 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • GERMANY
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Malaria Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • INDIA
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: India 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Malaria Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Malaria Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Malaria Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030
  • AFRICA
    • Malaria Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Malaria Treatment by Treatment - Generic Drug Treatment, Originators Treatment and Vaccines Treatment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Malaria Treatment by Treatment - Percentage Breakdown of Value Sales for Generic Drug Treatment, Originators Treatment and Vaccines Treatment for the Years 2014, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Malaria Treatment by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Malaria Treatment by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Distribution Channel for the Years 2014, 2025 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Malaria Treatment by Administration Route - Oral Administration and Parenteral Administration Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Malaria Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Parenteral Administration for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제